Emily Woodworth - 11 Aug 2026 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Reporting relationship: SVP, Global Controller and CAO
Issuer ticker: BSX
Reported as of: 11 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Aug 2026, 16:08:42 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Susan Thompson, Attorney-in-Fact

Key filing fact

Emily Woodworth filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 12 Aug 2026.

Key facts

This page summarizes Emily Woodworth's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Aug 2026, 16:08.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002013518 Primary reporting owner

Woodworth Emily

Relationship: SVP, Global Controller and CAO
Address: 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH
Signature: /s/ Susan Thompson, Attorney-in-Fact
Signature date: 12 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSX transaction

Common Stock

Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities

Transaction value
Shares: +2,930
Change %
Price: $51.19^*
Shares after: 2,930
Date: 11 Aug 2026
Ownership: By 401(k)
Footnotes: F1

BSX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,123
Date: 11 Aug 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.

Footnote F2

Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.